Dr. Jeffrey Shuren, director of FDA’s Center for Devices and Radiological Health, and colleagues shared the latest medtech-related updates during The Medtech Conference’s annual CDRH Town Hall.
After raising a sizable financing in June, Cue Health now has the support of a $481M award from the Department of Defense to expand production capacity of its COVID-19 test.
The company was awarded emergency use authorization for the AdviseDx SARS-CoV-2 IgM serology test. This makes the seventh test Abbott has received EUA for since the pandemic began.
